Hizentra 44206-0456-21
Generic: Human Immunoglobulin G
- Manufacturer
- Csl Behring Ag
- Dosage Form
- Liquid
- Route
- Subcutaneous
- Product Type
- Plasma Derivative
- Marketing Start
- January 1, 2020
- Listing Expires
- December 31, 2026
- Application
- BLA125350
Active Ingredients
| Ingredient | Strength |
|---|---|
| Human Immunoglobulin G | .2 g/mL |
Drug Class
Antigen Neutralization [MoA]Human Immunoglobulin G [EPC]Immunoglobulins [CS]
Selected Package
44206-0456-21Selected1 SYRINGE in 1 CARTON (44206-456-21) / 5 mL in 1 SYRINGE (44206-456-94)